BioArctic AB (B)

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP
W2R76M102
SEDOL
BDVP4H9
CIK
N/A
www.bioarctic.se
LEI:
©
FIGI: BBG00HVQ6XD7
BIOA B
BioArctic AB (B)
GICS: 35201010 · Sector: Health Care · Sub-Sector: Health Care
AI
PROFILER
NAME
BioArctic AB (B)
ISIN
SE0010323311
TICKER
BIOA B
MIC
XSTO
REUTERS
BIOAB.ST
BLOOMBERG
BIOAB SS
BUILD THEMEFOLIO SHARE IDEAS DISCUSS
LEVERAGE INVEST
EN 728x90
Financial Intelligence
360° iHub Crowd iFeed ATH Tracker Index Tracker ETF TF Spicy2 X-Billboard
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants
In this section you will find transaction histories for short sales.
ai
NALIZER
Short sellers are obliged to report when building up positions from 0.50% and when reducing positions up to 0.50%. If there are open positions >= 0.50% in the reporting registers, these are shown in the following overview.
Four Short sale positions >= 0.50% are currently registered as reportable-relevant
Date Position Holder Position # Action
17.06.2024 Qube Research & Technologies Limited 0,60% 2
20.05.2024 MILLENNIUM INTERNATIONAL MANAGEMENT LP 0,61% 59
10.07.2019 CITADEL ADVISORS LLC 0,50% 8
10.04.2019 MARSHALL WACE LLP 0,50% 12
The overview shows all positions and their last reported status. Please note that when reducing positions, falling below the 0.50% limit means that the mandatory reporting obligations no longer have to be applied. As a rule, it can be assumed that the positions have been completely reduced following a longer period of inactivity. Positions < 0.50% are therefore only of limited significance.
Date Position Holder Position # Action
17.06.2024 Qube Research & Technologies Limited 0,60% 2
20.05.2024 MILLENNIUM INTERNATIONAL MANAGEMENT LP 0,61% 59
10.07.2019 CITADEL ADVISORS LLC 0,50% 8
10.04.2019 MARSHALL WACE LLP 0,50% 12
SHORT SELLING RADAR (“SSR”)
SSR - First TIMER
SSR - DASHBOARD
HEDGE FUND ACTIVITY TRACKER
SSR Weight WATCHER
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements
The information provided in this area is compiled with care and prepared and processed in complex technical process steps. Quality assurance is an integral part of the methods and procedures used. A plausibility check is carried out to the extent that the source data allows. Before further use, especially in the course of any investment decisions, we recommend consulting at least one second independent source for validation.

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S